Tao Wenqi, Gong Miao, Ke Zunping
Department of Cardiology, Jing'an District Centre Hospital of Shanghai, Fudan University, Shanghai, China.
Department of Geriatrics, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
J Cell Mol Med. 2025 May;29(9):e70554. doi: 10.1111/jcmm.70554.
Cardiomyopathy encompasses a diverse range of conditions characterised by extensive molecular heterogeneity, particularly the variations in cell-cell communication events such as ligand-receptor interactions and downstream signalling. Understanding the common and unique features of these intercellular interactions is crucial for advancing targeted treatments. We analysed single-cell RNA sequencing datasets from the ventricular regions of patients with arrhythmogenic cardiomyopathy (ACM), dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM) and healthy donors (HD), as well as ischemic cardiomyopathy (ICM). Our analyses focused on cell type-specific disease preferences, differential gene expression, pathway enrichment and particularly cell-cell communication. We observed that inflammatory, autoimmune, angiogenesis, lymphangiogenesis and fibrotic extracellular matrix deposition are consistently enriched across all four disease subtypes, highlighting their universal significance in disease progression through intercellular interactions. Additionally, we identified subtype-specific pathways that reflect distinct intercellular communication patterns unique to each disease subtype: arrhythmia-associated pathways in ACM, chronic inflammation-related pathways in DCM, ECM remodelling pathways in HCM and ischaemic injury and recovery pathways in ICM.
心肌病涵盖了多种疾病,其特征是广泛的分子异质性,特别是细胞间通讯事件(如配体-受体相互作用和下游信号传导)的变化。了解这些细胞间相互作用的共同特征和独特特征对于推进靶向治疗至关重要。我们分析了来自致心律失常性心肌病(ACM)、扩张型心肌病(DCM)、肥厚型心肌病(HCM)患者以及健康供体(HD)的心室区域的单细胞RNA测序数据集,以及缺血性心肌病(ICM)。我们的分析集中在细胞类型特异性疾病偏好、差异基因表达、通路富集,特别是细胞间通讯。我们观察到炎症、自身免疫、血管生成、淋巴管生成和纤维化细胞外基质沉积在所有四种疾病亚型中均持续富集,突出了它们通过细胞间相互作用在疾病进展中的普遍意义。此外,我们确定了亚型特异性通路,这些通路反映了每种疾病亚型独特的不同细胞间通讯模式:ACM中的心律失常相关通路、DCM中的慢性炎症相关通路、HCM中的细胞外基质重塑通路以及ICM中的缺血损伤和恢复通路。